ARRDC4 and colorectal carcinoma: Consistent with knockdown of METTL14, the treatment of CRC cell lines with 3-deazaadenosine (DAA), a global methylation inhibitor, substantially increased the ARRDC4 mRNA and protein expression in CRC cells (Fig. 4G, H).